The overall rate of progression from MCI to AD was 16% per year during the 36-month study, the authors report.
作者在报告中提到，在这项为期36 个月的研究中，由遗忘型MCI向AD进展的总比率为每年16%。
Castline presented the results which showed that there was no improvement in the rate of progression of carotid atherosclerosis and the patients that got ezetimibe added on to simvastatin.
Castline博士报告的试验结果显示，患者联用伊替米贝和辛伐他汀时颈内动脉粥样硬化的进展速度没有改善。
Castline presented the results which showed that there was no improvement in the rate of progression of carotid atherosclerosis and the patients that got ezetimibe added on to simvastatin.
Castline博士报告的试验结果显示，患者联用伊替米贝和辛伐他汀时颈内动脉粥样硬化的进展速度没有改善。
应用推荐